Table 2. 2- and 5- Year Recurrence Free Survival Rates and Overall Survival Rates by Stage and Biomarker Groups.

Variable		RFS(95% CI)		OS (95% CI)
		2-year	5-year	2-year	5-year
Stage	I	74% (69%, 80%)	54% (48%, 61%)	87% (82%, 91%)	68% (62%, 75%)
	II	57% (47%, 70%)	35% (25%, 48%)	83% (74%, 92%)	51% (41%, 64%)
	III	41% (30%, 55%)	24% (15%, 38%)	57% (46%, 71%)	44% (33%, 59%)
m-Insulin receptor	0	70% (64%, 76%)	48% (42%, 55%)	84% (79%, 89%)	62% (56%, 70%)
	Positive	58% (50%, 66%)	40% (33%, 49%)	76% (69%, 83%)	58% (50%, 66%)
c-pAMPK	0	55% (47%, 65%)	33% (25%, 44%)	77% (70%, 86%)	52% (43%, 62%)
	Positive	69% (64%, 75%)	50% (44%, 57%)	82% (78%, 87%)	64% (59%, 71%)
c-pmTOR	0	53% (44%, 65%)	34% (25%, 45%)	69% (60%, 80%)	48% (38%, 60%)
	Positive	69% (64%, 74%)	49% (43%, 55%)	84% (80%, 89%)	65% (59%, 71%)
c-CXCR2	<Median	70% (63%, 77%)	49% (42%, 57%)	83% (78%, 89%)	66% (60%, 74%)
	>=Median	61% (54%, 68%)	41% (35%, 49%)	78% (73%, 85%)	55% (48%, 63%)
c-EPCAM	0	58% (50%, 67%)	39% (31%, 48%)	76% (69%, 84%)	51% (43%, 61%)
	Positive	69% (63%, 75%)	49% (43%, 56%)	84% (79%, 89%)	66% (60%, 73%)
n-FEN1	<Median	69% (63%, 77%)	50% (43%, 58%)	85% (80%, 91%)	68% (62%, 76%)
	>=Median	61% (54%, 68%)	41% (34%, 49%)	76% (70%, 83%)	54% (47%, 62%)